Aug 6, 2026 04:36PM
Aug 6, 2026 04:35PM
Apr 28, 2026 06:30AM
Apr 28, 2026 06:30AM
Jul 28, 2025 08:45AM
Jul 28, 2025 08:45AM
Jun 23, 2025 06:59AM Aclaris Therapeutics Initiates Phase 1a/1b Program for its Novel Bispecific Antibody ATI-052
May 8, 2025 06:50AM
Apr 22, 2025 06:59AM
Apr 22, 2025 06:59AM
Jan 30, 2025 04:04PM
Jan 30, 2025 04:01PM
Jan 10, 2024 07:00AM
Jan 10, 2024 07:00AM Aclaris Therapeutics Announces Top-line Results from 4-Week Phase 2b Trial of ATI-1777 for Mild to Severe Atopic Dermatitis
Nov 13, 2023 10:39AM
Nov 8, 2022 07:00AM
Nov 18, 2021 04:01PM
Sep 23, 2021 08:33AM
Aug 30, 2021 07:54AM
Jun 9, 2021 09:27AM
Jun 8, 2021 05:54PM After-Hours Stock Movers 06/08: (LYRA) (FSR) (LMNR) Higher; (ONDS) (CMTL) (PATH) Lower (more...)
Jan 20, 2021 09:20AM
Jan 19, 2021 05:44PM
Jul 8, 2020 09:24AM
Jul 7, 2020 05:49PM
Jul 7, 2020 04:02PM
Jul 7, 2020 04:01PM
Jun 17, 2020 09:27AM Pre-Open Movers 06/17: (WATT) (INWK) (GRPN) Higher; (CEMI) (ATNM) (NCLH) Lower (more...)
Jun 17, 2020 07:04AM
Jun 17, 2020 07:01AM
Nov 7, 2019 04:01PM
Oct 24, 2019 04:51PM
Oct 24, 2019 04:01PM
Oct 22, 2019 09:30AM
Oct 8, 2019 05:03PM Aclaris Therapeutics (ACRS) Files Patent Infringement Lawsuit Against Taro Pharmaceuticals, Inc. for Filing ANDA for Generic Version of RHOFADE cream, 1%
Oct 8, 2019 05:01PM
Sep 18, 2019 07:51PM
Sep 16, 2019 04:17PM
Sep 16, 2019 04:15PM
Sep 10, 2019 07:30PM
Sep 3, 2019 10:30PM
Aug 27, 2019 08:00AM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Oasmia Pharmaceutical, Aclaris Therapeutics, Evolent Health, and International Flavors & Fragrances and
Aug 18, 2019 07:30PM
Aug 11, 2019 07:25PM
Aug 8, 2019 04:01PM
Aug 5, 2019 09:30PM
Jul 30, 2019 08:20PM
Jul 30, 2019 04:39PM
Jul 30, 2019 04:01PM Aclaris Therapeutics Announces Phase 2 Clinical Trial of ATI-501 Oral in Patients with Alopecia Areata Met Primary Endpoint
Jul 9, 2019 07:03AM

328,282 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All